You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Screen for hepatitis B virus in all cancer patients starting systemic treatment. Find out more about hepatitis B virus screening and management.

Drug Formulary
About the Drug Formulary Email Drug Formulary Team

What’s New in the Drug Formulary

All new and recently updated drug and regimen monographs, patient information sheets, as well as safety and advice documents are available here.

Regimen
Published Date: 31 Mar 2026
Cancer Type:
Hematologic, 
Multiple Myeloma
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:
Regimen Monograph: Modified Rationale/uses and Pregnancy/Lactation sections, Removed bortezomib NDFP funding info
Updated
Mar 2026
Regimen
Published Date: 31 Mar 2026
Cancer Type:
Hematologic, 
Lymphoma - Non-Hodgkin's Low Grade
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Modified Rationale/uses section; Removed "Unfunded" info from bortezomib

Updated
Mar 2026
Regimen
Published Date: 31 Mar 2026
Cancer Type:
Hematologic, 
Multiple Myeloma
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Modified Rationale/uses section; Removed bortezomib NDFP funding info

Updated
Mar 2026
Regimen
Published Date: 31 Mar 2026
Cancer Type:
Hematologic, 
Multiple Myeloma
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Modified Rationale/uses section; Removed bortezomib NDFP funding info

Updated
Mar 2026
Regimen
Published Date: 26 Mar 2026
Cancer Type:
Breast
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Rationale/uses section (Added HR+, HER2-low or HER2-ultralow breast cancer – universal compassionate supply may be available)

Mar 2026
Drug

Published Date: 26 Mar 2026

Revision Summary:
Drug Monograph: Updated Pregnancy/Lactation section
Patient Info Sheet EN: Updated/revised information sheet
Patient Info Sheet FR: Updated/revised information sheet (Fiche d’information mise à jour/révisée)
Mar 2026
Regimen
Published Date: 25 Mar 2026
Cancer Type:
Hematologic, 
Lymphoma - Non-Hodgkin's Low Grade
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Formatting change only

Mar 2026
Drug

Published Date: 25 Mar 2026

Revision Summary:
Drug Monograph: Updated Pregnancy/Lactation section
Patient Info Sheet EN: Updated/revised information sheet
Patient Info Sheet FR: Updated/revised information sheet (Fiche d'information mise à jour/revisée)
Mar 2026
Regimen
Published Date: 24 Mar 2026
Cancer Type:
Gastrointestinal, 
Mesothelioma (Peritoneal), 
Lung, 
Mesothelioma (Pleural)
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:
Patient Info Sheet EN: New patient regimen information sheet
Mar 2026
Regimen
Published Date: 24 Mar 2026
Cancer Type:
Lung, 
Non-Small Cell
Show More Show more tags
, Show Less Show fewer tags
Intent: Neoadjuvant
Revision Summary:
Patient Info Sheet EN: New patient regimen information sheet
Mar 2026
Drug

Published Date: 18 Mar 2026

Revision Summary:


Drug Monograph: Updated Supplementary Public Funding section

Mar 2026
Regimen
Published Date: 18 Mar 2026
Cancer Type:
Gynecologic, 
Endometrial
Show More Show more tags
, Show Less Show fewer tags
Intent: Adjuvant, Curative, Palliative
Revision Summary:

Regimen Monograph: Updated Rationale/Uses and Cycle Frequency sections

Mar 2026

Pages